Cipher Pharma buys Canadian rights to novel treatment for psoriasis and RA from Can-Fite Biopharma
Cipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel ...